These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 28267674)
21. Radiosensitization of metformin in pancreatic cancer cells via abrogating the G2 checkpoint and inhibiting DNA damage repair. Wang Z; Lai ST; Ma NY; Deng Y; Liu Y; Wei DP; Zhao JD; Jiang GL Cancer Lett; 2015 Dec; 369(1):192-201. PubMed ID: 26304716 [TBL] [Abstract][Full Text] [Related]
22. Enhancement of radiation sensitivity of human squamous carcinoma cells by histone deacetylase inhibitors. Zhang Y; Jung M; Dritschilo A; Jung M Radiat Res; 2004 Jun; 161(6):667-74. PubMed ID: 15161353 [TBL] [Abstract][Full Text] [Related]
23. Suberoylanilide hydroxamic acid increases anti-cancer effect of tumor necrosis factor-α through up-regulation of TNF receptor 1 in lung cancer cells. You BR; Han BR; Park WH Oncotarget; 2017 Mar; 8(11):17726-17737. PubMed ID: 28099148 [TBL] [Abstract][Full Text] [Related]
24. Paris Saponins enhance radiosensitivity in a gefitinib-resistant lung adenocarcinoma cell line by inducing apoptosis and G2/M cell cycle phase arrest. Zhao PJ; Song SC; Du LW; Zhou GH; Ma SL; Li JH; Feng JG; Zhu XH; Jiang H Mol Med Rep; 2016 Mar; 13(3):2878-84. PubMed ID: 26846193 [TBL] [Abstract][Full Text] [Related]
25. The anti-tumor effects and molecular mechanisms of suberoylanilide hydroxamic acid (SAHA) on the aggressive phenotypes of ovarian carcinoma cells. Chen S; Zhao Y; Gou WF; Zhao S; Takano Y; Zheng HC PLoS One; 2013; 8(11):e79781. PubMed ID: 24236158 [TBL] [Abstract][Full Text] [Related]
26. Cyclopamine increases the radiosensitivity of human pancreatic cancer cells by regulating the DNA repair signal pathway through an epidermal growth factor receptor‑dependent pathway. Wu XY; Che J; Sun KK; Shen XJ; Yang D; Zhong N; Zhao H Mol Med Rep; 2013 Oct; 8(4):979-83. PubMed ID: 23903906 [TBL] [Abstract][Full Text] [Related]
27. Radiosensitizing effects of gefitinib at different administration times in vitro. Zhuang HQ; Sun J; Yuan ZY; Wang J; Zhao LJ; Wang P; Ren XB; Wang CL Cancer Sci; 2009 Aug; 100(8):1520-5. PubMed ID: 19432883 [TBL] [Abstract][Full Text] [Related]
28. RNAi silencing targeting RNF8 enhances radiosensitivity of a non-small cell lung cancer cell line A549. Zhou H; Mu X; Chen J; Liu H; Shi W; Xing E; Yang K; Wu G Int J Radiat Biol; 2013 Sep; 89(9):708-15. PubMed ID: 23578064 [TBL] [Abstract][Full Text] [Related]
29. Suberoylanilide hydroxamic acid (Zolinza/vorinostat) sensitizes TRAIL-resistant breast cancer cells orthotopically implanted in BALB/c nude mice. Shankar S; Davis R; Singh KP; Kurzrock R; Ross DD; Srivastava RK Mol Cancer Ther; 2009 Jun; 8(6):1596-605. PubMed ID: 19509267 [TBL] [Abstract][Full Text] [Related]
30. Synergistic loss of prostate cancer cell viability by coinhibition of HDAC and PARP. Chao OS; Goodman OB Mol Cancer Res; 2014 Dec; 12(12):1755-66. PubMed ID: 25127709 [TBL] [Abstract][Full Text] [Related]
31. 5-aza-2'-Deoxycytidine enhances the radiosensitivity of breast cancer cells. Wang L; Zhang Y; Li R; Chen Y; Pan X; Li G; Dai F; Yang J Cancer Biother Radiopharm; 2013 Feb; 28(1):34-44. PubMed ID: 22917213 [TBL] [Abstract][Full Text] [Related]
32. Flavopiridol, a cyclin-dependent kinase inhibitor, enhances radiosensitivity of ovarian carcinoma cells. Raju U; Nakata E; Mason KA; Ang KK; Milas L Cancer Res; 2003 Jun; 63(12):3263-7. PubMed ID: 12810657 [TBL] [Abstract][Full Text] [Related]
33. Suberoylanilide hydroxamic acid (SAHA) enhances olaparib activity by targeting homologous recombination DNA repair in ovarian cancer. Konstantinopoulos PA; Wilson AJ; Saskowski J; Wass E; Khabele D Gynecol Oncol; 2014 Jun; 133(3):599-606. PubMed ID: 24631446 [TBL] [Abstract][Full Text] [Related]
34. Benzyl isothiocyanate sensitizes human pancreatic cancer cells to radiation by inducing apoptosis. Ohara M; Kimura S; Tanaka A; Ohnishi K; Okayasu R; Kubota N Int J Mol Med; 2011 Dec; 28(6):1043-7. PubMed ID: 21833466 [TBL] [Abstract][Full Text] [Related]
35. [Evodiamine enhances the radiosensitivity of esophageal squamous cell cancer Eca-109 cells]. Feng H; Guo B; Kong X; Wu B Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jul; 32(7):940-4. PubMed ID: 27363277 [TBL] [Abstract][Full Text] [Related]
36. Suberoylanilide hydroxamic acid enhances the radiosensitivity of lung cancer cells through acetylated wild-type and mutant p53-dependent modulation of mitochondrial apoptosis. Wu K; Chen X; Chen X; Zhang S; Xu Y; Xia B; Ma S J Int Med Res; 2021 Feb; 49(2):300060520981545. PubMed ID: 33557658 [TBL] [Abstract][Full Text] [Related]
37. HDAC inhibitor PCI-24781 decreases RAD51 expression and inhibits homologous recombination. Adimoolam S; Sirisawad M; Chen J; Thiemann P; Ford JM; Buggy JJ Proc Natl Acad Sci U S A; 2007 Dec; 104(49):19482-7. PubMed ID: 18042714 [TBL] [Abstract][Full Text] [Related]
38. Suberoylanilide hydroxamic acid as a potential therapeutic agent for human breast cancer treatment. Huang L; Pardee AB Mol Med; 2000 Oct; 6(10):849-66. PubMed ID: 11126200 [TBL] [Abstract][Full Text] [Related]
39. Anticancer effects of suberoylanilide hydroxamic acid in esophageal squamous cancer cells in vitro and in vivo. Tzao C; Jin JS; Chen BH; Chung HY; Chang CC; Hsu TY; Sun GH Dis Esophagus; 2014; 27(7):693-702. PubMed ID: 24033428 [TBL] [Abstract][Full Text] [Related]
40. In vivo efficacy of the histone deacetylase inhibitor suberoylanilide hydroxamic acid in combination with radiotherapy in a malignant rhabdoid tumor mouse model. Thiemann M; Oertel S; Ehemann V; Weichert W; Stenzinger A; Bischof M; Weber KJ; Perez RL; Haberkorn U; Kulozik AE; Debus J; Huber PE; Battmann C Radiat Oncol; 2012 Mar; 7():52. PubMed ID: 22458853 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]